Xeris Biopharma Holdings (XERS) Times Interest Earned (2020 - 2025)
Historic Times Interest Earned for Xeris Biopharma Holdings (XERS) over the last 6 years, with Q3 2025 value amounting to $0.92.
- Xeris Biopharma Holdings' Times Interest Earned rose 15578.24% to $0.92 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.33, marking a year-over-year increase of 12180.15%. This contributed to the annual value of -$1.1 for FY2024, which is 3330.23% up from last year.
- As of Q3 2025, Xeris Biopharma Holdings' Times Interest Earned stood at $0.92, which was up 15578.24% from $0.61 recorded in Q2 2025.
- Xeris Biopharma Holdings' 5-year Times Interest Earned high stood at $0.92 for Q3 2025, and its period low was -$26.82 during Q4 2021.
- Its 5-year average for Times Interest Earned is -$5.05, with a median of -$2.14 in 2023.
- Its Times Interest Earned has fluctuated over the past 5 years, first plummeted by 53774.61% in 2021, then soared by 15918.41% in 2025.
- Quarter analysis of 5 years shows Xeris Biopharma Holdings' Times Interest Earned stood at -$26.82 in 2021, then surged by 87.05% to -$3.47 in 2022, then surged by 59.58% to -$1.4 in 2023, then surged by 115.53% to $0.22 in 2024, then surged by 322.86% to $0.92 in 2025.
- Its Times Interest Earned was $0.92 in Q3 2025, compared to $0.61 in Q2 2025 and -$0.42 in Q1 2025.